Related references
Note: Only part of the references are listed.Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia
A. Vilas-Zornoza et al.
LEUKEMIA (2012)
Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: The molecular choreography
Larry H. Thompson
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2012)
ADAMANTANYL-HISTONE DEACETYLASE INHIBITOR H6CAHA EXHIBITS FAVORABLE PHARMACOKINETICS AND AUGMENTS PROSTATE CANCER RADIATION SENSITIVITY
Zacharoula Konsoula et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Histone Deacetylases 9 and 10 Are Required for Homologous Recombination
Shweta Kotian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Grand rounds at the National Institutes of Health: HDAC inhibitors as radiation modifiers, from bench to clinic
Jacob E. Shabason et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy
Ase Bratland et al.
RADIATION ONCOLOGY (2011)
Targeting abnormal DNA double strand break repair in cancer
Feyruz V. Rassool et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Mre11-Rad50-Nbs1 conformations and the control of sensing, signaling, and effector responses at DNA double-strand breaks
Gareth J. Williams et al.
DNA REPAIR (2010)
The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax
Aaron A. Goodarzi et al.
DNA REPAIR (2010)
ENHANCEMENT OF RADIATION RESPONSE IN OSTEOSARCOMA AND RHABOMYOSARCOMA CELL LINES BY HISTONE DEACETYLASE INHIBITION
Claudia Blattmann et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study
Anne Hansen Ree et al.
LANCET ONCOLOGY (2010)
Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining
Kyle M. Miller et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor
Sushant K. Kachhap et al.
PLOS ONE (2010)
HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy
Omar Khan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair
J-H. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
Julia M. Wagner et al.
Clinical Epigenetics (2010)
HDAC Inhibitor, Valproic Acid, Induces p53-Dependent Radiosensitization of Colon Cancer Cells
Xufeng Chen et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
Successful Treatment of Anaplastic Thyroid Carcinoma with a Combination of Oral Valproic Acid, Chemotherapy, Radiation and Surgery
Hitoshi Noguchi et al.
ENDOCRINE JOURNAL (2009)
Inhibition of vimentin or β1 integrin revert morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo
Xueping Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?
L. Nolan et al.
BRITISH JOURNAL OF CANCER (2008)
Acute toxicity in a Phase II clinical trial of Valproic Acid in combination with temodar and radiation therapy in patients with glioblastoma multiforme
M. Kamrava et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination
Shanthi Adimoolam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The role of histone deacetylases (HDACs) in human cancer
Santiago Ropero et al.
MOLECULAR ONCOLOGY (2007)
Histone deacetylase (HDAC) inhibitor LBH589 increases duration of γ-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer
Ling Geng et al.
CANCER RESEARCH (2006)
Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of γ-H2AX foci
Anupama Munshi et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity
A Munshi et al.
CLINICAL CANCER RESEARCH (2005)
Modulation of radiation response by histone deacetylase inhibition
P Chinnaiyan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Share Paper
